Merck signs $290m deal with Orion Corporation for mCRPC candidate ODM-208
Merck has signed a global development and commercialization deal worth $290 million with Orion Corporation for the latter’s investigational candidate ODM-208 and other drugs that ... Read More
Infosys roped in by Orion to transform ERP and planning platforms
Infosys has been roped in by Orion Corporation, a Finnish pharma company, to transform its enterprise resource planning (ERP) and planning platforms, boost employee experience, ... Read More